Sio Gene Therapies Inc (SIOX) Return on Assets ROA from the third quarter of 2023 to third quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Dec 31 2022 to Dec 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Sio Gene Therapies Inc   (NASDAQ: SIOX)


Sio Gene Therapies Inc 's ROA from the third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Sio Gene Therapies Inc 's ROA in the third quarter of 2023?
Sio Gene Therapies Inc recorded a cumulative net loss of $-29 million during 12 months ending in the third quarter of 2023, resulting in a negative return on assets (ROA) of -49.31%.

However, within the Healthcare sector 815 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2023 from 5091 to 5441.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2022)
III. Quarter		 (Sep 30 2022)
II. Quarter		 (Jun 30 2022)
I. Quarter		 (Mar 31 2022)
IV. Quarter		 (Dec 31 2021)
III. Quarter
Y / Y Total Assets Change -47.88 % -50.91 % -50.45 % -46.12 % -8.36 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -29 -50 -68 -72 -62
Return On Assets (TTM) -49.31 % -72.51 % -82.18 % -72.92 % -54.23 %
SIOX's Total Ranking # 5441 # 5091 # 5295 # 5186 # 5357
Total Assets (TTM) in million 47 54 60 73 91
Seq. Total Assets Change -12.03 % -10.75 % -17.1 % -19.91 % -17.16 %
Seq. Net Income Change - - - - -

SIOX's 5 Years Annual ROA >> Back to SIOX Management Effectiveness >> Compare SIOX ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 360
Sector # 816
Overall # 5275

Return On Assets Statistics
High Average Low
-32.78 %
-79.55 %
-124.55 %
(Jun 30 2021)   (Dec 31 2018)





Financial Statements
Sio Gene Therapies Inc 's Assets $ 47 million SIOX's Balance sheet
Sio Gene Therapies Inc 's Income $ -4 million Quarterly SIOX's Income Statement
SIOX's Income by Division See SIOX's Income by Division



Annual Return On Assets (Mar 31 2022)
FY 2022		 (Mar 31 2021)
FY 2021		 (Mar 31 2020)
FY 2020		 (Mar 31 2019)
FY 2019		 (Mar 31 2018)
FY 2018
Y / Y Total Assets Change -46.12 % 43.91 % -23.65 % -23.68 % -27.75 %
Total Assets in million 73 135 94 123 161
Y / Y Net Income Change - - - - -
Net Income in million -72 -32 -73 -129 -222
Annual Return On Assets -98.97 % -24.05 % -77.53 % -105.18 % -137.81 %

SIOX's 5 Years Annual ROA >> Back to SIOX Management Effectiveness >> Compare SIOX ROA to its Competitors



More Return On Assets Ratios
SIOX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SIOX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SIOX's Competitors
Subscribers only: Roa for Sio Gene Therapies Inc 's Suppliers
Subscribers only: Return On Assets for SIOX's Customers

You may also want to know
SIOX's Roi SIOX's Inventory Turnover Ratio SIOX's Growth Rates SIOX's Dividend Comparisons
SIOX's Profitability Ratios SIOX's Asset Turnover Ratio SIOX's Dividend Growth
SIOX's Roe SIOX's Valuation Ratios SIOX's Financial Strength Ratios SIOX's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2022, within Healthcare Sector ROA

Date modified: 2026-06-22T14:32:26+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.